Taken together, our findings suggest that EZH2 down-regulates the expression of GSK-3β and TP53 by specifically and directly binding to the promoters of GSK-3β and TP53 via histone methylation in cervical cancer cells. This evidence concerns the gene TP53 and cervical carcinoma.